Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine
NCT ID: NCT02513043
Last Updated: 2022-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1470 participants
OBSERVATIONAL
2016-03-22
2021-05-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Telemedicine Medical Abortion
NCT04599725
Feasibility of Medical Abortion by Telemedicine in Mexico
NCT03931460
The Feasibility of Simplified Telephone Follow-up After Medical Abortion
NCT00619658
Medication Abortion With Autonomous Self-Assessment Project
NCT05278780
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan.
NCT05459142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
medical abortion
medical abortion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
10 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gynuity Health Projects
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erica Chong, MPH
Role: PRINCIPAL_INVESTIGATOR
Gynuity Health Projects
Elizabeth Raymond, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Gynuity Health Projects
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Planned Parenthood of the Rocky Mountains
Denver, Colorado, United States
Carafem
Washington D.C., District of Columbia, United States
Carafem
Atlanta, Georgia, United States
The University of Hawaii Women's Options Centers
Honolulu, Hawaii, United States
Carafem
Skokie, Illinois, United States
Emma Goldman Clinic
Iowa City, Iowa, United States
Maine Family Planning
Augusta, Maine, United States
Carafem
Chevy Chase, Maryland, United States
Planned Parenthood Minnesota, North Dakota, South Dakota
Saint Paul, Minnesota, United States
Planned Parenthood of Montana
Billings, Montana, United States
Planned Parenthood of the Rocky Mountains
New Mexico, New Mexico, United States
Choices Women's Medical Center
Jamaica, New York, United States
Maine Family Planning
New York, New York, United States
Planned Parenthood Columbia Willamette
Portland, Oregon, United States
Oregon Health and Sciences University Women's Health Research Unit
Portland, Oregon, United States
Planned Parenthood Columbia Willamette
Washington, Washington, United States
Oregon Health and Sciences University Women's Health Research Unit
Washington, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.